Loading...
YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C
BACKGROUND/AIMS: The aim of this study was to explore the association of a functional YKL-40 promoter polymorphism (rs4950928) with baseline disease stage, response to antiviral therapy, and risk of liver disease progression in a group of patients with chronic hepatitis C (CHC). METHODS: YKL-40 prom...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3299849/ https://ncbi.nlm.nih.gov/pubmed/22103814 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1478-3231.2011.02686.x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|